PKO Investment Management Joint-Stock’s C4 Therapeutics CCCC Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-35,000	Closed	-$264K	–	136
2022 Q2	$264K	Buy	+35,000	New	+$264K	0.04%	120